Orexigen Therapeutics Inc. (OREX)
NASDAQ: Health Care
$3.44
-0.02 | -0.72%
-0.02 | -0.72%
Today's Range:
3.41 -
3.46
OREX Avg. Daily Volume:
1,615,600
05/30/12 - 9:59 AM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.47 |
| 52 Week High | 5.14 |
| 52 Week Low | 1.22 |
| Avg. Daily Vol. (Mil) | 1.48 |
| Beta (3 year) | 2.87 |
| Share Related Items | |
| Mkt Cap (Mil) | 235.19 |
| Shares Out (Mil) | 67.78 |
| Float (Mil) | 60.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 16.00 |
| Current Ratio | 16.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 68.61 |
| Price/Book | 2.59 |
| Price/Cash Flow | -9.20 |
| Per Share Data | |
| Earnings | -0.51 |
| Sales | 0.05 |
| Book Value | 1.34 |
| Cash Flow | -0.38 |
| Business Summary | |
|---|---|
| A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. | |
| General Information | |
| 3344 North Torrey Pines Cour
Suite 200 La Jolla, CA 92037 |
|
| www.orexigen.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 23 | |
| CEO: Michael A. Narachi | |
| Short Interest | |
| Current Month (Mil) | 3.88 |
| Previous Month (Mil) | 3.75 |
| Short Interest Ratio (Days) | 3.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -19.10 |
| Return on Investments | -29.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,436.44 | 1,317.76 | 2,833.00 | 16.53 |
Oil *
103.92
|
|
DOWN
144.25 |
DOWN
14.66 |
DOWN
37.99 |
DOWN
0.78 |
10 Yr
1.65%
SPDR Gold
149.34
|
|
-1.15%
|
-1.10%
|
-1.32%
|
-4.51%
|
Data delayed 20 minutes |
Connect with TheStreet